Token Agency - Tokenomics - STO and ICO specialists | Dermavir
ICO, Blockchain, Dermavir
ICO, Blockchain, Dermavir
portfolio_page-template-default,single,single-portfolio_page,postid-16670,ajax_fade,page_not_loaded,,vertical_menu_enabled, vertical_menu_transparency vertical_menu_transparency_on,qode-title-hidden,qode-content-sidebar-responsive,qode-theme-ver-16.7,qode-theme-bridge,disabled_footer_top,disabled_footer_bottom,wpb-js-composer js-comp-ver-5.6,vc_responsive
Advisory, ICO
About This Project

Advisory for DermaVir – ┬áCan it change the treatment paradigm of HIV? This is the question this privately held clinical-stage biotechnology company is focusing on by developing and commercialising a revolutionary new immunotherapy technology platform for the treatment of chronic viral infections, cancer and allergy. Their Platform Technology includes an antigen specific plasmid DNA (pDNA) that is encapsulated in a nanomedicine formulation to make it closely resemble a virus, and a topical (through the skin) administration device. Their Lead Therapeutic Vaccine for treatment of HIV, referred to as ”Derma Vir” is effective in boosting immune response which in turn kills HIV-infected cells. See DermaVir.